---
title: "Bharat Immunological & Biological Corporation Ltd (524663) — Share Price, Financials & Analysis"
symbol: "524663"
company: "Bharat Immunological & Biological Corporation Ltd"
canonical: "https://tapetide.com/stocks/524663"
isin: "INE994B01014"
nse_symbol: "BHARATIMMUNOLOGICALSBIOLOGICALSCORPORATIONLTD"
bse_code: "524663"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 64.75
generated_at: "2026-09-13T19:38:16.783Z"
---

# Bharat Immunological & Biological Corporation Ltd (524663)

Canonical page: https://tapetide.com/stocks/524663

## Company

- **NSE Symbol:** BHARATIMMUNOLOGICALSBIOLOGICALSCORPORATIONLTD
- **BSE Code:** 524663
- **ISIN:** INE994B01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bibcol.com

## About

Incorporated in 1989, Bharat Immunological and Biologicals Corporation Ltd manufactures biotechnology-based pharmaceuticals.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:51:38.032704Z.

- **Market Cap:** ₹64.75 Cr
- **Classification:** Microcap
- **P/E (reported):** -3.6
- **EPS (reported):** ₹0
- **Book Value:** ₹-7.54
- **Price to Book:** -2
- **Dividend Yield:** 0%
- **ROE:** -19.43%
- **ROCE:** -16.78%
- **Debt to Equity:** 0.8
- **Revenue (yearly):** ₹47.4 Cr
- **Net Income:** ₹-17.1 Cr
- **EBITDA:** ₹-15.7 Cr
- **52-Week High:** ₹22.61
- **52-Week Low:** ₹14.1
- **RSI (14):** 34.63

## Tapetide Score

- **Score:** 42 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Falling
- **Percentile:** 19.7 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 12.2 | 9% |
| growth | 1.1 | 9% |
| momentum | 34.7 | 12% |
| ownership | 50 | 24% |
| quality | 33.72 | 22% |
| valuation | 72.28 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.83 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.09% over past five years.
- Company has a low return on equity of -22.7% over last 3 years.
- Debtor days have increased from 39.6 to 114 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 125.85% | -7.56% | 133.93% |
| ebitda margin growth | -7.14% | 577.05% | 49.77% | 469.66% |
| net income growth | -6.52% | 94.32% | -31% | 194.83% |
| revenue growth | 100% | -40.38% | -13% | 5% |
| roce | — | 357.22% | -65.54% | -24.02% |
| roe | — | 133.81% | -26.98% | 2.91% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 25.2 | 15.62 | 14.22 | 24.7 | 17.43 | 22.04 | 10.48 | 26.48 | 0 | 7.65 | 0 | 0 |
| Expenses | 27.47 | 31.54 | 13.18 | 28.19 | 16.41 | 25.71 | 15.31 | 28.98 | 4.72 | 11.67 | 4.31 | 4.68 |
| Operating Profit | -2.27 | -15.92 | 1.04 | -3.49 | 1.02 | -3.67 | -4.83 | -2.5 | -4.72 | -4.02 | -4.31 | -4.68 |
| OPM % | -9.01 | -101.92 | 7.31 | -14.13 | 5.85 | -16.65 | -46.09 | -9.44 | — | -52.55 | — | — |
| Other Income | 1.2 | 9.08 | 0.25 | 0.22 | 0.12 | 0.59 | 0.14 | 0.32 | 0.1 | 0.49 | 0.1 | 0.16 |
| Interest | 1.3 | 1.22 | 1.16 | 1.23 | 1.54 | 1.68 | 1.58 | 1.74 | 1.67 | 2.06 | 1.72 | 2.09 |
| Depreciation | 0.06 | 0.06 | 0.06 | 0.06 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.09 | 0.03 | 0.03 |
| Profit before tax | -2.43 | -8.12 | 0.07 | -4.56 | -0.44 | -4.81 | -6.31 | -3.96 | -6.33 | -5.68 | -5.96 | -6.64 |
| Tax % | -21.81 | -19.46 | -2642.86 | 105.26 | -25 | -11.02 | -20.76 | -22.22 | -26.07 | -31.69 | -23.15 | -26.05 |
| Net Profit | -1.89 | -6.53 | 1.93 | -9.36 | -0.33 | -4.28 | -5 | -3.08 | -4.68 | -3.88 | -4.59 | -4.92 |
| EPS in Rs | -0.44 | -1.51 | 0.45 | -2.17 | -0.08 | -0.99 | -1.16 | -0.71 | -1.08 | -0.9 | -1.06 | -1.14 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 146 | 128 | 124 | 35 | 84 | 67 | 85 | 78 | 45 | 8 |
| Expenses | 143 | 132 | 111 | 43 | 93 | 77 | 106 | 83 | 63 | 25 |
| Operating Profit | 3 | -4 | 13 | -8 | -9 | -10 | -21 | -5 | -18 | -18 |
| OPM % | 2.3 | -3.1 | 10 | -23 | -11 | -16 | -24 | -6 | -41 | -232 |
| Other Income | 1 | 1 | 1 | 1 | 4 | 1 | 2 | 1 | 3 | 1 |
| Interest | 1 | 6 | 4 | 1 | 2 | 5 | 5 | 6 | 7 | 8 |
| Depreciation | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 2 | -9 | 9 | -8 | -7 | -14 | -24 | -10 | -23 | -25 |
| Tax % | 26 | -31 | 29 | -46 | -21 | -28 | -25 | -10 | -25 | — |
| Net Profit | 2 | -6 | 7 | -4 | -6 | -10 | -18 | -9 | -17 | -18 |
| EPS in Rs | 0.36 | -1.44 | 1.51 | -0.99 | -1.34 | -2.36 | -4.19 | -2.03 | -3.95 | -4.18 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves | -2 | -8 | -1 | -6 | -12 | -23 | -9 | 62 | 45 | 36 |
| Borrowings | -9 | 9 | 0 | 0 | 32 | 3 | 27 | 78 | 70 | 74 |
| Other Liabilities | 48 | 24 | 17 | 16 | 62 | 103 | 43 | 29 | 28 | 35 |
| Total Liabilities | 80 | 68 | 59 | 53 | 125 | 127 | 104 | 213 | 186 | 188 |
| Fixed Assets | 6 | 6 | 5 | 5 | 5 | 4 | 4 | 116 | 115 | 115 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 74 | 63 | 53 | 48 | 120 | 122 | 68 | 97 | 70 | 73 |
| Total Assets | 80 | 68 | 59 | 53 | 125 | 127 | 104 | 213 | 186 | 188 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -12 | 8 | -9 | -17 | 3 | -32 | 34 | 12 | -42 | 11 |
| Cash from Investing Activity | 0 | 0 | 1 | 0 | -1 | 1 | 1 | 1 | 1 | 0 |
| Cash from Financing Activity | -6 | -1 | -2 | -3 | -1 | 31 | -34 | -12 | 45 | -15 |
| Net Cash Flow | -18 | 7 | -10 | -20 | 1 | -1 | 1 | 0 | 3 | -3 |
| Free Cash Flow | -12 | 8 | -9 | -17 | 3 | -32 | 34 | 12 | -42 | 11 |
| CFO/OP | -99 | 229 | 239 | -132 | -32 | 344 | -328 | -56 | 847 | -59 |

### Ratios

| Item | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 47 | 34 | 37 | 19 | 167 | 318 | 96 | 0 | 5 | 114 |
| Inventory Days | 66 | 84 | 77 | 2 | 23 | 67 | 308 | 56 | 202 | 13 |
| Days Payable | 70 | 103 | 26 | 1 | 6 | 204 | 259 | 61 | 5 | 4 |
| Cash Conversion Cycle | 43 | 16 | 88 | 19 | 185 | 181 | 145 | -5 | 203 | 122 |
| Working Capital Days | 21 | 20 | 28 | -19 | 59 | 10 | -108 | -174 | -227 | -549 |
| ROCE % | 42 | 9 | -8 | 31 | -18 | -11 | -22 | -46 | -3 | -9 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% | 59.25% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 37.5% | 38.51% | 39.58% | 38.77% | 39.15% | 39.11% | 38.86% | 38.97% | 39.13% | 39.3% | 39.35% | 39.47% |
| Others | 3.25% | 2.24% | 1.17% | 1.97% | 1.59% | 1.63% | 1.88% | 1.77% | 1.61% | 1.45% | 1.39% | 1.28% |
| No. of Shareholders | 38195 | 36799 | 36869 | 36323 | 35695 | 35411 | 36242 | 35535 | 34818 | 34201 | 34910 | 35313 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 15.31 | Sell |
| EMA (10) | 15.31 | Sell |
| SMA (20) | 15.6 | Sell |
| EMA (20) | 15.52 | Sell |
| SMA (50) | 16.01 | Sell |
| EMA (50) | 15.97 | Sell |
| SMA (100) | 16.73 | Sell |
| EMA (100) | 16.55 | Sell |
| SMA (200) | 17.54 | Sell |
| EMA (200) | 17.69 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.62 | Neutral |
| MACD (12,26,9) | -0.26 | Sell |
| Stochastic (14,3,3) | 8.43 | Buy |
| ADX (14) | 20.09 | Neutral |
| Williams %R (14) | -94.75 | Buy |
| ATR (14) | 0.71 | High Volatility |
| ROC (12) | -5.44 | Sell |
| Stoch RSI (14) | 27.67 | Neutral |
| UO (7,14,28) | 23.1 | Buy |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Ms. Ching Chun Yang resigned as Independent Director of D-Link India effective 5 February 2026; ceases committee memberships. | [Announcement under Regulation 30 (LODR)-Resignation of Director 9 Feb - Ms. Ching Chun Yang resigned as Independent Director of D-Link India effective 5 February 2026; ceases committee memberships.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a9a9e064-8996-43a7-84de-6a8bfd46ad8c.pdf) |
| 7 Aug 2024 - Board meeting scheduled for August 16, 2024. | [Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR. 7 Aug 2024 - Board meeting scheduled for August 16, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/810f8c08-9c5d-43b5-9860-2a6c971992ba.pdf) |
| 5 Feb - Board approved Q3 results; customs demand ₹611.49 lakh (19 Jan 2026); director resigned 5 Feb 2026. | [Financial Results For The Quarter Ended December 31, 2025 5 Feb - Board approved Q3 results; customs demand ₹611.49 lakh (19 Jan 2026); director resigned 5 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f87f6157-340d-450a-975b-09ed81d15666.pdf) |
| 5 Feb - Approved Q3/9M results; Rs611.49 lakh customs demand; Ms. Ching Chun Yang resigned effective 05-Feb-2026. | [Board Meeting Outcome for Outcome Of The Board Meeting 5 Feb - Approved Q3/9M results; Rs611.49 lakh customs demand; Ms. Ching Chun Yang resigned effective 05-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29308d8f-9b57-42d0-b503-18c7e7e0bbae.pdf) |
| 5 Feb - Approved Q3/9M results; Independent director resigned; Customs demand ₹611.49 lakh (19 Jan 2026). | [Announcement under Regulation 30 (LODR)-Resignation of Director 5 Feb - Approved Q3/9M results; Independent director resigned; Customs demand ₹611.49 lakh (19 Jan 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c164387-1cec-4370-8110-a4548abac064.pdf) |
| 29 Feb 2024 - Board meeting scheduled for March 8, 2024. | [Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR. 29 Feb 2024 - Board meeting scheduled for March 8, 2024.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aae1238a-b7d0-4633-bfb6-96d7c43c879c.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d0a61f14-d112-4810-9350-bde65708ecd6.pdf) |
| — | [Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023. 13 Dec 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e65ca743-d241-4e82-9141-a57167ecb1cb.pdf) |
| — | [Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015. 28 Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cc7fd21e-68ea-449a-8473-ef5818d08c8c.pdf) |
| — | [Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (22.12.2023 To 29.12.2023) Of The Company In Respect Of 34Th Annual General Meeting Scheduled To Be Held On 29.12.2023. 28 Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eec8aaf8-1e14-4497-abfc-3d9aa82df906.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2011 from nse](https://archives.nseindia.com/annual_reports/AR_DLINKINDIA_2010_2011_14072011110502.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/feb3ccd1-e374-4ebb-b407-21b1cd7d5454.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8999aa13-b573-4d58-9878-e03f87a9617b.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/775045b7-f29b-4e1d-8c36-9f6d89a0b334.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533146/73727533146.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524663/77366524663.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533146/69400533146.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524663/72706524663.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/533146/65288533146.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524663/68259524663_12_01_21.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2024-08-07 | [Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBI'S LODR.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=810f8c08-9c5d-43b5-9860-2a6c971992ba.pdf) |
| 2024-02-29 | [Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aae1238a-b7d0-4633-bfb6-96d7c43c879c.pdf) |
| 2023-12-13 | [Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e65ca743-d241-4e82-9141-a57167ecb1cb.pdf) |
| 2023-11-28 | [Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc7fd21e-68ea-449a-8473-ef5818d08c8c.pdf) |
| 2023-11-28 | [Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (22.12.2023 To 29.12.2023) Of The Company In Respect Of 34Th Annual General Meeting Scheduled To Be Held On 29.12.2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eec8aaf8-1e14-4497-abfc-3d9aa82df906.pdf) |
| 2023-10-19 | [Board Meeting Intimation for Intimation Of Date Of Board Meeting On 31St October 2023 Under Regulation 29 Of SEBI'S LODR.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29689290-0286-43c6-b994-12903fcdaa07.pdf) |
| 2023-09-15 | [Submission Of Signed Audited Annual Accounts 2022-23 Alongwith Statutory Audit Report Thereof Provided By The Statutory Auditor Appointed By Comptroller & Auditor General Of India (C&AG).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=543b2599-cfb8-4efd-a344-007e0979f554.pdf) |
| 2023-05-10 | [Compliance Certificate Under Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ending On 31.03.2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27e8574f-701e-4cf0-b4e9-c2d070a1c05c.pdf) |
| 2023-05-10 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3da80609-62a8-438f-b8be-f324dffa1d6d.pdf) |
| 2023-04-27 | [Certificate From Practicing Company Secretary Under Regulation 40 (9) Of SEBI (LODR) Regulations 2015 For The Year Ended 31.03.2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=081289ec-2df9-4f44-a941-75fb596abfbe.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2023-11-01 | [Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter Ended June 2023 As Compliance Of LODR 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4775e67-90ac-439a-89fa-5e0bc3373931.pdf) |
| 2023-11-01 | [Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter And Half Year Ended September 2023 As Compliance Of LODR 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a63fc9c8-092a-4f17-bbe6-aca097597773.pdf) |
| 2023-05-31 | [Submission Of Annual Accounts For The Financial Year Ended On 31.03.2023 And Is Under Audit Of Statutory Auditor Appointed By C&AG](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8a25682-95c2-4b95-ba63-f9a514453182.pdf) |
| 2023-02-10 | [Submission Of Unaudited Quarterly Financial Results For The Quarter And Nine Months Ended December 2022 Along With Limited Review Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b30b22cc-6476-4d18-b5f9-3d765650394a.pdf) |
| 2022-10-17 | [Board Meeting Outcome for Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended September 2022 And Limited Review Report Thereon As Per The Compliance Of LODR 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d19c6c2c-7049-441f-b9f2-a9d25469cbca.pdf) |
| 2022-08-15 | [Board Meeting Outcome for Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended June 2022 And Limited Review Report Thereon As Per The Compliance Of LODR 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a36848b3-fea3-4b54-be79-09c9e3877bea.pdf) |
| 2022-05-31 | [Submission Of Reviewed Annual Financial Results For The Year Ended 31.03.2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf03b373-4836-4600-9f02-33c19b26aaf0.pdf) |
| 2022-02-09 | [Board Meeting Outcome for Submission Of Unaudited Quarterly Financial Results For The Quarter Ended December 2021 As Compliance Of LODR 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc3922f7-e741-44ec-a3a2-41e317bf208b.pdf) |
| 2022-02-09 | [Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended December 2021 Under Regulation 33(3)(C ) Of LODR](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e3a4ab8-f9ae-467b-b183-15946f09461c.pdf) |
| 2021-11-15 | [Submission Of Limited Review Report Of The Quarterly Unaudited Financial Results For The Quarter Ended September 2021 Under Regulation 33(3)(C ) Of LODR](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd17d3f5-dc81-498c-8152-d1d01a1e2b9e.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:38:16.783Z.